Natural killer (NK) cell-based therapies have made great progress in treating both hematological and solid tumors. Their unique mechanism of action does not rely on antigen presentation to recognize and eliminate tumor cells, making them a promising approach for cancer immunotherapy. In this review, we present a comprehensive summary of the latest clinical data of the novel NK cell-based therapies from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, highlighting the potential of these advancements to revolutionize the treatment of hematologic malignancies and solid tumors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287938 | PMC |
| http://dx.doi.org/10.1186/s13045-024-01575-0 | DOI Listing |
Publication Analysis
Top Keywords
cell-based therapies
12
natural killer
8
killer cell-based
8
solid tumors
8
novel natural
4
therapies hematologic
4
hematologic solid
4
solid malignancies
4
malignancies latest
4
latest updates
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!